The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 14) read more.....»»
The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) read more.....»»
Stocks have had a wild ride. Here"s what may dictate where markets go next
While the month of May could become the crucial period to assess the quality and quantum of this economic rebound, analysts warn there are still a few red flags to watch out for......»»
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020
VANCOUVER and HOUSTON, May 7, 2020 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:EPIX, TSXV:EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpora.....»»
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. read more.....»»
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along wi.....»»
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. read more.....»»
The Daily Biotech Pulse: FDA Approves Sanofi"s Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs April 23.) Arcturus Therapeutics .....»»
Against backdrop of shelter-in-place, Peninsula biotech asks FDA to approve prostate cancer drug
Filing thousands of pages of data electronically from remote locations as employees sheltered in place against Covid-19, Myovant Sciences asked regulators Tuesday to quickly approve its once-a-day pill against prostate cancer. The Brisbane company a.....»»
The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) Chembio Diagnostics Inc (NASDAQ: CEMI) Cytosorbents Corp (N.....»»
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark"s COVID-19 Test
Here's a roun.....»»
Pharmaceutical Companies Gain in the Fight Against Covid-19
Shares of several pharma and biotech companies are up sharply over the past monthRelated Stocks: REGN, MRNA, INO, GILD, ABBV, RHHBY, TMO, JNJ, BTNX, PFE, VIR,.....»»
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and.....»»
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccine news. read more.....»»
The Wuhan Virus and Research-Focused Biotech Companies
With the spread of the new coronavirus from Wuhan, investors should consider investing in smaller biotech and pharma playersRelated Stocks: GILD, REGN, NNVC, INO, CODX,.....»»
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) read more.....»»
The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight
Biotech stocks recovered last week along with the broader markets, which bounced back from a China coronavirus-induced sell-off. Big pharma earnings took the spotlight, with Merck & Co., Inc. .....»»
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN) Aptose Biosciences .....»»
These 4 Biotech Stocks Are the Silver Lining on the Wuhan Coronavirus
Anti-viral pharma companies catering to respiratory disorders performed solidly during the SARS outbreak, and history might repeat itself with this new virusRelated Stocks: GSK, ABT, GILD, NNVC, UAL, AAL, EXPE,.....»»
The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche"s Cancer Drug Flunks Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 23) 0 read more.....»»